Philip Rose is the Managing Director of Rose Pharma Solutions. Philip has over 20 years’ experience in a wide range of roles within the pharmaceutical industry from Quality Control (QC) through to senior management and as a Qualified Person under the EU permanent provisions.
Before consultancy, Philip worked as a Lead Senior GMDP Inspector for the UK competent authority, the Medicines and Healthcare products Regulatory Agency (MHRA). Within this role he inspected some of the most complex cases globally against the requirements of EU GMP and GDP in areas such as biologicals (including vaccines), steriles, non-steriles, advanced therapy medicinal products (ATMPs) and UK “Specials”. This included inspections on behalf of EMA (European Medicines Agency) and leading joint inspections with EMA and US FDA.
Philip was a member of the MHRA’s Compliance Management Team (CMT) and was the inspectorate technical lead for biological medicinal products and previously the technical lead for steriles. He was also a member of the Inspectorate’s cross-contamination working group.
Philip is fully conversant with current regulations and is able to bring a wealth of experience from his time as a regulator together with his experience within industry.
He is one of the only consultants available worldwide, who was accredited and worked as an EU Inspector in biological and advanced therapy medicinal products.
